Skip to content
Discover the latest news, history, and insights about the B…

Zimbabwe Turns Down ‘One-Sided’ American Health Aid Deal Because of Data Fears

Medical funding image
The proposed US financial assistance would have supported initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has turned down a major US health deal worth $367m (£272m) spanning five years over the United States' demand for sensitive information.

This move was revealed following a government memo from December was disclosed, which showed President Emmerson Mnangagwa believed the agreement was "unbalanced".

An official spokesman later stated that the United States was seeking biological samples for research and profit but was not willing to guarantee the benefits from future treatments.

"We will now turn to the difficult and regrettable task of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy said the United States had furnished more than $1.9bn as health assistance to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has urged more dialogue to reach a deal suitable to all parties so the nation's critical HIV treatment initiative can proceed.

Broader Context

This rejection comes after a similar case in Kenya, where a high court halted a similar deal with the US after concerns were raised about the safety of citizens' health data.

Since resuming office last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.

The agency had overseen aid for the US government, but Trump argued its expenditure was "inefficient" and his administration was pursuing government-to-government deals to enhance openness and accountability.

Based on reports, Sixteen African countries have to date agreed to similar agreements, representing over $18.3bn in new funding.

Specifics of the Rejected Deal

The money for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this cooperation might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving HIV treatment via US-supported initiatives," Tremont added.

However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".

"Our nation was requested to surrender its genetic material and health information indefinitely, with no corresponding assurance of access to any scientific breakthroughs – such as new medicines or tests – that could result from that shared data," he stated.

"In essence, our nation would provide the basic resources for medical research without any certainty that the resulting innovations would be available to our population should a future disease outbreak emerge."

Sovereignty and Global Health

Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting systems previously set up through the international health agency.

Mangwana cited its Pathogen Access and Benefit Sharing framework created to manage future pandemics.

"This framework is designed to ensure that when a nation provides its samples, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised solely by those with the funds to create them."

These objections over the US deal "should not be misconstrued as anti-American sentiment," he added.

"We welcome continued dialogue with our American counterparts on how future co-operation might be structured in a way that honours the independence and dignity of each country."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but recommended that talks need to persist considering much of the country's Aids initiatives relied on foreign aid.

"Where specific concerns arise, such as those involving data governance or implementation frameworks, these can frequently be resolved through technical clarification and mutually agreed protections," the group added.

This impasse underscores the complex tensions between accepting much-needed foreign assistance and safeguarding national sovereignty in an increasingly data-driven world.

CS
About the author

Carrie Smith

A royal historian and writer with a passion for uncovering the stories behind the Crown.

London Royal Insight

Type to search articles.